| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Outline of Final Research Achievements |
Liver stem cell-derived liver cancer is classifiable into a typical, mixed, cholangiolocellular subtypes. These diagnostics, prognosis and treatment is not determined.
In this retrospective study, though we couldn't determine the specific findings in typical and mixed type, we could reveal that cholangiolocellular subtype showed characteristic findings on dynamic CT/MRI and low accumulation of FDG compared with ordinaly cholangiocellular carcinoma. Furthermore there were different cancer gene expressions between cholangiolocellular subtype and intrahepatic cholangiocellular carcinoma. We believe that cholangiolocellular subtype is unique and it should be considered as a independent disease from ordinary cholangiocellular carcinoma.
|
